MEDEOR THERAPEUTICS
Medeor Therapeutics is a developer of cellular immunotherapies designed to improve outcomes in organ transplant recipients. The company's cellular immunotherapies consist of approaches to organ transplant immune tolerance and immuno-oncology, enabling healthcare providers to preserve or improve transplant kidney function and prevent graft rejection better than currently available immunosuppression (anti-rejection) drugs.
MEDEOR THERAPEUTICS
Industry:
Biotechnology Pharmaceutical Therapeutics
Founded:
2012-01-01
Address:
South San Francisco, California, United States
Country:
United States
Website Url:
http://www.medeortx.com
Total Employee:
1+
Status:
Active
Contact:
650-627-4531
Email Addresses:
[email protected]
Total Funding:
75.8 M USD
Technology used in webpage:
SPF Apache Microsoft Exchange Online Office 365 Mail Microsoft Azure DNS GoDaddy DNS Google Google Cloud GoDaddy SSL Google Cloud Global Multi-Region
Similar Organizations
Aimmune Therapeutics
Aimmune Therapeutics is a clinical-stage biopharmaceutical company that improves the lives of people with food allergies.
Apeiron Biologics
Apeiron Biologics is a biotech company that focuses on the discovery and development of novel cancer immunotherapies.
Axcella
Axcella is a biotechnology company that treats diseases using endogenous metabolic modulators.
Cedilla Therapeutics
Cedilla Therapeutics is a biotechnology company that develops targeted small molecules for the treatment of cancer and other diseases.
Imvax
Imvax is a biotechnology company focused on the development of novel patient-specific vaccines and immunotherapy strategies.
Moderna Therapeutics
Moderna Therapeutics is a biotechnology company that specializes in drug discovery and drug development based on messenger RNA.
Ocumension Therapeutics
Ocumension Therapeutics is a pharmaceutical platform dedicated to identifying, developing, and commercializing ophthalmic therapies.
RiMO Therapeutics
RiMO technology enhances state-of-the-art immunosuppression inhibitor-based cancer immunotherapy.
Santi Therapeutics
Santi Therapeutics is a pharmaceutical company that focuses on the research and development of small molecule therapeutics.
Alaunos Therapeutics
Alaunos Therapeutics is a biotechnology company that acquires, develops, and commercializes cancer therapies.
Current Advisors List
Current Employees Featured
Founder
Investors List
California Institute for Regenerative Medicine
California Institute for Regenerative Medicine investment in Grant - Medeor Therapeutics
Vivo Capital
Vivo Capital investment in Series B - Medeor Therapeutics
Sofinnova Investments
Sofinnova Investments investment in Series B - Medeor Therapeutics
RA Capital Management
RA Capital Management investment in Series B - Medeor Therapeutics
WuXi Healthcare Ventures
WuXi Healthcare Ventures investment in Series B - Medeor Therapeutics
6 Dimensions Capital
6 Dimensions Capital investment in Series B - Medeor Therapeutics
Official Site Inspections
http://www.medeortx.com Semrush global rank: 5.56 M Semrush visits lastest month: 1.53 K
- Host name: 41.113.180.107.host.secureserver.net
- IP address: 107.180.113.41
- Location: Scottsdale United States
- Latitude: 33.6013
- Longitude: -111.8867
- Metro Code: 753
- Timezone: America/Phoenix
- Postal: 85260
More informations about "Medeor Therapeutics"
Home | Medeor Therapeutics
For business development inquiries, please contact [email protected]. When two immune systems come together, prolonged organ survival for patients without …See details»
About Us - Medeor Therapeutics
Our company was founded with a life-changing mission in mind: to enable the immune system in one human to benefit another. Our goals include a world in which organ transplant patients are …See details»
Board of Directors - Medeor Therapeutics
View the Board of Directors for Medeor Therapeutics.See details»
Medeor Therapeutics Company Profile 2024: Valuation, Funding ...
Information on valuation, funding, cap tables, investors, and executives for Medeor Therapeutics. Use the PitchBook Platform to explore the full profile.See details»
Medeor Therapeutics, Inc. | LinkedIn
Our immunotherapy is positioned to improve the lives of transplant patients and people living with immune, and hematological diseases. We envision a future where more transplant patients are …See details»
Medeor Therapeutics - Crunchbase Company Profile & Funding
Medeor Therapeutics is a biotechnology company that dedicates to dedicates to the development of personalized cellular immunotherapies. View contacts for Medeor Therapeutics to access …See details»
Medeor Therapeutics Completes Enrollment and ... - Business Wire
May 12, 2021 · Patients are being evaluated for the efficacy and safety of its drug candidate MDR-101 to establish immune tolerance that allows for the complete withdrawal of …See details»
Medeor Therapeutics to Provide Interim Results of Phase 3 …
May 20, 2021 · Medeor’s Phase 3 tolerance study is a randomized, multi-center study evaluating the establishment of functional immune tolerance in MDR-101 recipients of HLA-matched …See details»
Medeor Therapeutics’ Transplant Immune Tolerance Therapy …
Sep 22, 2020 · Medeor Therapeutics is working to improve the lives of transplant patients by eliminating or reducing the need for a life-long regimen of immunosuppressant medications …See details»
Our Focus - Medeor Therapeutics
From solid organ transplants to immune and hematological diseases, our vision is to apply our platform to help more people live better lives. Learn why we are dedicated to leveraging the …See details»
Medeor Therapeutics - Overview, News & Similar companies
May 20, 2021 · View Medeor Therapeutics (www.medeortx.com) location in California, United States , revenue, industry and description. Find related and similar companies as well as …See details»
Medeor Therapeutics - VentureRadar
Website: http://medeortx.com. Develops therapies to enhance transplant patient lives by reducing or eliminating reliance on immunosuppressive medications and minimizing harmful side …See details»
Medeor Therapeutics Completes Enrollment and Transplantation …
May 12, 2021 · Medeor has additional pipeline research that will be initiated in the coming months. Details can be found at https://www.medeortx.com/our-pipeline/clinical-trials.php. …See details»
Medeor Therapeutics Announces Data Presentation at the …
Sep 30, 2020 · Medeor’s Phase 3 clinical study is demonstrating the significant opportunities of this one-time therapy. For more information, visit www.medeortx.com.See details»
Medeor Therapeutics’ Transplant Immune Tolerance Therapy
Sep 22, 2020 · Medeor Therapeutics is working to improve the lives of transplant patients by eliminating or reducing the need for a life-long regimen of immunosuppressant medications …See details»
Physicians | Transforming Patient Health - Medeor Therapeutics
We aim to maintain organ function after surgery and reduce graft failures. Our chimeric immunotherapies have the potential to result in improved long-term tolerance for transplant …See details»
Medeor’s Cell Therapy MDR-101 Allows Patients to Taper off ...
Nov 10, 2023 · Medeor Therapeutics' MDR-101, a one-time donor blood-derived cell therapy for kidney transplant recipients, has surpassed its primary efficacy endpoint in a phase 3 clinical …See details»
Medeor Therapeutics - Craft
Medeor Therapeutics (formerly known as SERC) is a company engaged in the research, development, and commercialization of transformative and personalized cellular …See details»
Clinical Trials - Medeor Therapeutics
View our Clinical Trials for Solid and Non-Solid Organ Transplant.See details»
Cyprus could become a member of NATO when conditions permit, …
10 hours ago · The Associated Press is an independent global news organization dedicated to factual reporting. Founded in 1846, AP today remains the most trusted source of fast, …See details»